Use of Patient-Reported Outcomes in Risk Prediction Model Development to Support Cancer Care Delivery: A Scoping Review
PURPOSE The integration of patient-reported outcomes (PROs) into electronic health
records (EHRs) has enabled systematic collection of symptom data to manage post …
records (EHRs) has enabled systematic collection of symptom data to manage post …
[HTML][HTML] Prostate cancer risk calculators for healthy populations: systematic review
A Bandala-Jacques, KD Castellanos Esquivel… - JMIR cancer, 2021 - cancer.jmir.org
Background Screening for prostate cancer has long been a debated, complex topic. The use
of risk calculators for prostate cancer is recommended for determining patients' individual …
of risk calculators for prostate cancer is recommended for determining patients' individual …
Incorporation of urinary prostate cancer antigen 3 and TMPRSS2: ERG into prostate cancer prevention trial risk calculator
Abstract Background The Prostate Cancer Prevention Trial Risk Calculator (PCPTRC) is a
commonly used risk tool for predicting the outcome on biopsy based on the established risk …
commonly used risk tool for predicting the outcome on biopsy based on the established risk …
Development and validation of models to predict pathological outcomes of radical prostatectomy in regional and national cohorts
Purpose: Prediction models are recommended by national guidelines to support clinical
decision making in prostate cancer. Existing models to predict pathological outcomes of …
decision making in prostate cancer. Existing models to predict pathological outcomes of …
Prediction of visual acuity in patients with microbial keratitis
Purpose: The purpose of this study was to predict visual acuity (VA) 90 days after
presentation for patients with microbial keratitis (MK) from data at the initial clinical …
presentation for patients with microbial keratitis (MK) from data at the initial clinical …
Engaging patients in complex clinical decision-making: Successes, pitfalls, and future directions
AA Laviana, SC Pannell, KHY Huen… - … Oncology: Seminars and …, 2017 - Elsevier
Background By 2022, there will be 18 million predicted cancer survivors, which is an
estimated 30% more than the number of survivors in 2012. In prostate cancer alone, the …
estimated 30% more than the number of survivors in 2012. In prostate cancer alone, the …
Association of 5-Alpha Reductase Inhibitor Use with Prostate Specific Antigen Level at the Time of Urology Referral in a Retrospective Cohort at a Large, Integrated …
JT Kearns, JT Matulay, WE Anderson… - Urology …, 2021 - auajournals.org
Abstract Introduction: 5-Alpha reductase inhibitor (5-ARI) use leads to a 50% decline in
serum prostate specific antigen (PSA) without a concomitant decrease in prostate cancer …
serum prostate specific antigen (PSA) without a concomitant decrease in prostate cancer …